calendar
10,394 catalysts · 3,153 8k filing · 2,253 grant · 1,170 approval · 1,000 device adverse event · 885 device 510k · 633 device pma
10,394 catalysts · 3,153 8k filing · 2,253 grant · 1,170 approval · 1,000 device adverse event · 885 device 510k · 633 device pma
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493 — Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. — Status: Ongoing
ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA — Reason: cGMP Deviations — Status: Ongoing
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15 — Reason: Out of specification for dissolution. — Status: Ongoing
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30 — Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. — Status: Ongoing
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01. — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1 — Reason: Presence of particulate matter - Glass like particles. — Status: Ongoing
Product code: ODP. Advisory committee: Orthopedic. Type: Traditional
Product code: OXO. Advisory committee: Radiology. Type: Traditional
Product code: GXN. Advisory committee: Neurology. Type: Traditional
Product code: MOS. Advisory committee: Radiology. Type: Special
Product code: LZC. Advisory committee: General Hospital. Type: Traditional
Product code: IYE. Advisory committee: Radiology. Type: Special
Product code: QJI. Advisory committee: Clinical Chemistry. Type: Traditional
Product code: BTT. Advisory committee: Anesthesiology. Type: Traditional
Product code: KRD. Advisory committee: Cardiovascular. Type: Traditional
Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional
Supplement type: Special (Immediate Track). Product code: LMH. Advisory committee: SU. Decision: APPR
Supplement type: Special (Immediate Track). Product code: MCX. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: SDL. Advisory committee: AN. Decision: OK30
Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30
Supplement type: Normal 180 Day Track No User Fee. Product code: PLJ. Advisory committee: SU. Decision: APPR
Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPT. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: EZW. Advisory committee: GU. Decision: OK30
PIE PAK Models: P2HC-A, P2HC-S, P2HC — Reason: Lack of 510K clearance — Status: Ongoing
PIE Trolley System Model: 2005 — Reason: Lack of 510K clearance — Status: Ongoing
GM grant. $196,875. PI: Stephania A Cormier
Sponsor: AJANTA PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL
Sponsor: KADMON PHARMS LLC. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: INJECTION
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS. Form: TABLET. Route: ORAL
Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS
Sponsor: SHANDONG. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL
Product code: ODP. Advisory committee: Orthopedic. Type: Special
Product code: PGM. Advisory committee: Orthopedic. Type: Traditional
Product code: ITI. Advisory committee: Physical Medicine. Type: Traditional